These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Specific enzymatic assay for D-glucarate in human serum. Blumenthal HJ; Lucuta VL; Blumenthal DC Anal Biochem; 1990 Mar; 185(2):286-93. PubMed ID: 2187374 [TBL] [Abstract][Full Text] [Related]
5. Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. Lecamwasam DS; Franklin C; Turner P Br J Clin Pharmacol; 1975 Jun; 2(3):257-62. PubMed ID: 1234506 [TBL] [Abstract][Full Text] [Related]
6. Acetaminophen metabolism by cytochrome P450 monooxygenases in Parkinson's disease. Factor SA; Weiner WJ; Hefti F Ann Neurol; 1989 Aug; 26(2):286-8. PubMed ID: 2774516 [TBL] [Abstract][Full Text] [Related]
7. Hepatic enzyme induction and its relationship to urinary D-glucaric acid excretion in man. Lecamwasam DS Br J Clin Pharmacol; 1975 Dec; 2(6):546-8. PubMed ID: 1234021 [No Abstract] [Full Text] [Related]
8. Phenytoin parahydroxylation is not impaired in patients with young-onset Parkinson's disease. Peeters EA; Bloem BR; Kuiper MA; Vermeij P; de Wolff FA; Wolters EC; Roos RA; Ferrari MD Clin Neurol Neurosurg; 1994 Nov; 96(4):296-9. PubMed ID: 7889690 [TBL] [Abstract][Full Text] [Related]
9. P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's disease. Riedl AG; Watts PM; Brown CT; Jenner P Adv Neurol; 1999; 80():271-86. PubMed ID: 10410732 [No Abstract] [Full Text] [Related]
10. Indirect evidence for hepatic induction in patients with cholesterol gallstones. Sandle LN; Worthington HV; Rameh B; Braganza JM Biochem Soc Trans; 1997 Aug; 25(3):412S. PubMed ID: 9388642 [No Abstract] [Full Text] [Related]
11. CHANGES IN ENZYME ACTIVITY, RELATED TO D-GLUCARIC ACID SYNTHESIS, WITH AGE, PREGNANCY AND MALIGNANCY. MARSH CA; CARR AJ Clin Sci; 1965 Apr; 28():209-17. PubMed ID: 14277294 [No Abstract] [Full Text] [Related]
12. Cytochrome P450 and Parkinson's disease. Poor parahydroxylation of phenytoin. Ferrari MD; Peeters EA; Haan J; Roos RA; Vermey P; de Wolff FA; Buruma OJ J Neurol Sci; 1990 May; 96(2-3):153-7. PubMed ID: 2376747 [TBL] [Abstract][Full Text] [Related]
13. [Sparteine oxidation by hepatic cytochrome P-450 in patients with Parkinson's disease]. Yoshino H; Hattori Y; Imai H; Narabayashi H; Chiba K Rinsho Shinkeigaku; 1993 Mar; 33(3):261-5. PubMed ID: 8334787 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease. Pár A; Horváth T; Beró T; Kádas I; Pakodi F; Jávor T Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369 [TBL] [Abstract][Full Text] [Related]
16. D-glucaric-acid excretion as a test for hepatic enzyme induction. Aarts EM Lancet; 1971 Apr; 1(7704):859. PubMed ID: 4102545 [No Abstract] [Full Text] [Related]
17. Mechanisms of lung cancer chemoprevention by D-glucarate. Walaszek Z; Hanausek M; Narog M; Raich PC; Slaga TJ Chest; 2004 May; 125(5 Suppl):149S-50S. PubMed ID: 15136472 [No Abstract] [Full Text] [Related]
19. Effect of liver regeneration on hepatic cytochrome P450 isozymes and serum sex steroids in the male rat. Liddle C; Murray M; Farrell GC Gastroenterology; 1989 Mar; 96(3):864-72. PubMed ID: 2914647 [TBL] [Abstract][Full Text] [Related]
20. Estimation of the functional reserve of the human liver by urinary D-glucaric acid excretion after vitamin C administration. Hanaue H; Kanno K; Mukai M; Kubo H; Tobita K; Nakasaki H; Tajima T; Mitomi T; Endo R Tokai J Exp Clin Med; 1993 Jun; 18(1-2):1-4. PubMed ID: 7940601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]